Bendamustine supercharge plus brentuximab vedotin as early salvage therapy following failure to obtain complete metabolic remission after two cycles of adriamycin-bleomycin-vinblastine-dacarbazine for classic Hodgkin lymphoma in patients aged ≤ 60 years: Long-term efficacy results of a retrospective multicentre study.
作者信息
Giordano C, Picardi M, Pugliese N, Vincenzi A, Avilia S, De Fazio L, Lamagna M, Reina R, Scarpa A, Lombardi A, Vigliar E, Troncone G, Mascolo M, Mainolfi C, Fonti R, Del Vecchio S, Damiano V, Bianco R, Trastulli F, Annunziata M, Salemme A, Carchia M, Pane F
机构信息
Department of Clinical Medicine and Surgery, Federico II University Medical School, Naples, Italy.
Department of Public Health, Federico II University Medical School Naples, Naples, Italy.
出版信息
Br J Haematol. 2025 May;206(5):1502-1507. doi: 10.1111/bjh.20053. Epub 2025 Apr 2.
Abstract
摘要
Zotero 插件